Medclair AB
NNGM:MCLR2.76
SEK
-0.02
(-0.72%)
ISIN
SE0009190572
Return %
Stock
S&P 500
1Y
-1.08
14.20
3Y
84.74
81.12
5Y
14.76
68.34
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.Company Description
- CEO
- Jonas Lundh
- Sector
- Health technology
- Industry
- Medical specialties
- Address
- Stockholm Sweden
- IPO Date
- Mar 3, 2017
- Website
- medclair.com
- Similar Companies
- Business
- Medclair AB is a Sweden-based cleantech and medical technology company that develops, manufactures, and commercializes proprietary systems for the measurement, collection, catalytic destruction, and recycling of nitrous oxide emissions. Founded in 2013 and headquartered in Stockholm, Sweden, the company operates within the healthcare, dental, and waste management sectors across more than 20 countries globally, providing solutions that eliminate greenhouse gas emissions and safeguard personnel against occupational gas exposure in hospitals, maternity wards, outpatient clinics, and industrial recycling centers. Medclair AB offers a specialized product and service portfolio that includes the Mobile Destruction Unit, a mobile catalytic destruction system designed for flexible point-of-care use across individual treatment rooms; the Central Destruction Unit, a high-capacity stationary decomposition installation integrated with hospital ventilation infrastructure to treat nitrous oxide extracted from multiple operating suites simultaneously; the Recycling Decomposition Unit, an industrial system engineered for waste management and metal recycling facilities to safely evacuate and neutralize residual nitrous oxide from discarded gas cylinders; the EXPO.p and Nitrous Oxide Detector product lines, comprising wearable personal sensors and continuous stationary monitoring systems for real-time occupational exposure tracking and regulatory compliance; and complementary installation, maintenance, evacuation tooling, and technical validation services. In recent corporate developments, Medclair AB restructured its operational architecture by formally merging its wholly-owned subsidiary, Medclair Sweden AB, into the parent entity to enhance governance and operational efficiency. The company has also accelerated its international commercial expansion by securing an exclusive framework agreement with Resah, one of France's largest public healthcare purchasing networks; expanding its exclusive distribution partnership with BeaconMedaes, an Atlas Copco Group company, across the United Kingdom and Ireland; scaling its distribution network in Germany alongside Nippon Gases; and securing major multi-million SEK supply agreements for its Recycling Decomposition Units across the UK and Scotland.